Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ardan Equity is a private equity investment firm focused exclusively on healthcare and life sciences software and data companies. The firm describes itself as a sector-specialized buyout manager and alternative investment manager that partners with founders and management teams to scale market-leading platforms. Its investment themes span life sciences, providers, payers, pharmacy, and related healthcare end markets rather than drug development. Ardan appears to be an active private company, founded in 2018, with offices in Palm Beach, Boston, and Chicago. It is not a biotech drug developer, CRO, or pharma company, but it is healthcare-related through its investment focus on the digital healthcare and life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ardan Equity Partners.